23 Jul Shoreline Biosciences
Dan Kaufman, M.D., Ph.D., Co-Founder and Chief Science Officer
Oct. 12 | 3:00pm | BlueRock Therapeutics Ballroom
San Diego, CA
Shoreline Biosciences develops genetically engineered induced pluripotent stem cell (iPSC)-derived allogeneic natural killer and macrophage products that are intelligently designed for greater potency and persistence. With our deep expertise in iPSC differentiation methods and genetic reprogramming, we strive to intelligently advance oncological and regenerative cell therapies by improving upon and overcoming the variety of limitations of earlier cell therapies.